{"PubmedArticle":{"MedlineCitation":{"@attributes":{"Status":"PubMed-not-MEDLINE","Owner":"NLM"},"PMID":{"@attributes":{"Version":"1"},"@text":"31360464"},"DateRevised":{"Year":"2022","Month":"04","Day":"09"},"Article":{"@attributes":{"PubModel":"Electronic-eCollection"},"Journal":{"ISSN":{"@attributes":{"IssnType":"Print"},"@text":"2050-0068"},"JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"8","Issue":"7","PubDate":{"Year":"2019"}},"Title":"Clinical & translational immunology","ISOAbbreviation":"Clin Transl Immunology"},"ArticleTitle":"Associations of pathogen-specific and host-specific characteristics with disease outcome in patients with <i>Staphylococcus aureus<\/i> bacteremic pneumonia.","Pagination":{"StartPage":"e01070","MedlinePgn":"e01070"},"ELocationID":[{"@attributes":{"EIdType":"pii","ValidYN":"Y"},"@text":"e01070"},{"@attributes":{"EIdType":"doi","ValidYN":"Y"},"@text":"10.1002\/cti2.1070"}],"Abstract":{"AbstractText":[{"@attributes":{"Label":"OBJECTIVE","NlmCategory":"OBJECTIVE"},"@text":"To understand the relationships of <i>Staphylococcus aureus<\/i> (SA) bacteremic pneumonia (SABP) outcome with patient-specific and SA-specific variables."},{"@attributes":{"Label":"METHODS","NlmCategory":"METHODS"},"@text":"We analysed SA bloodstream isolates and matching sera in SABP patients by sequencing SA isolates (<i>n<\/i>\u00a0=\u00a050) and measuring <i>in\u00a0vitro<\/i> AT production, haemolytic activity and expression of ClfA and ClfB. Controls were sera from gram-negative bacteremia patients with or without pneumonia and uninfected subjects. Levels of IgGs, IgMs and neutralizing antibodies (NAbs) against SA antigens were quantified and analysed by one-way ANOVA. Associations of patient outcomes with patient variables, antibody levels and isolate characteristics were evaluated by univariate and multivariate logistic regression analyses."},{"@attributes":{"Label":"RESULTS","NlmCategory":"RESULTS"},"@text":"SABP patients had higher levels of IgGs against eight virulence factors and anti-alpha toxin (AT) NAbs than uninfected controls. Levels of IgG against AT and IgMs against ClfA, FnbpA and SdrC were higher in clinically cured SABP patients than in clinical failures. Anti-LukAB NAb levels were elevated in all cohorts. Increased odds of cure correlated with higher haemolytic activity of SA strains, longer time between surgery and bacteremia (&gt;\u00a030\u00a0days), longer duration of antibiotic therapy, lower acute physiology and total APACHE II scores, lack of persistent fever for &gt;\u00a072\u00a0h and higher levels of antibodies against AT (IgG), ClfA (IgM), FnbpA (IgM) and SdrC (IgM)."},{"@attributes":{"Label":"DISCUSSION","NlmCategory":"CONCLUSIONS"},"@text":"Limitations included the cross-sectional observational nature of the study, small sample size and inability to measure antibody levels against all SA virulence factors."},{"@attributes":{"Label":"CONCLUSION","NlmCategory":"CONCLUSIONS"},"@text":"Our results suggest that SABP patients may benefit from immunotherapy targeting multiple SA antigens."}]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Sharma-Kuinkel","ForeName":"Batu K","Initials":"BK","AffiliationInfo":[{"Affiliation":"Division of Infectious Diseases, Department of Medicine, Duke University Durham NC USA."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Tkaczyk","ForeName":"Christine","Initials":"C","AffiliationInfo":[{"Affiliation":"Microbial Sciences, AstraZeneca Gaithersburg MD USA."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonnell","ForeName":"Jessica","Initials":"J","AffiliationInfo":[{"Affiliation":"Microbial Sciences, AstraZeneca Gaithersburg MD USA."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Yu","ForeName":"Li","Initials":"L","AffiliationInfo":[{"Affiliation":"Statistical Sciences, AstraZeneca Gaithersburg MD USA."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Tovchigrechko","ForeName":"Andrey","Initials":"A","AffiliationInfo":[{"Affiliation":"Data Science &amp; Artificial Intelligence, AstraZeneca Gaithersburg MD USA."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Tabor","ForeName":"David E","Initials":"DE","AffiliationInfo":[{"Affiliation":"Microbial Sciences, AstraZeneca Gaithersburg MD USA."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Park","ForeName":"Lawrence P","Initials":"LP","AffiliationInfo":[{"Affiliation":"Division of Infectious Diseases, Department of Medicine, Duke University Durham NC USA."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Ruffin","ForeName":"Felicia","Initials":"F","AffiliationInfo":[{"Affiliation":"Division of Infectious Diseases, Department of Medicine, Duke University Durham NC USA."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Esser","ForeName":"Mark T","Initials":"MT","AffiliationInfo":[{"Affiliation":"Microbial Sciences, AstraZeneca Gaithersburg MD USA."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Sellman","ForeName":"Bret R","Initials":"BR","AffiliationInfo":[{"Affiliation":"Microbial Sciences, AstraZeneca Gaithersburg MD USA."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Fowler","ForeName":"Vance G","Initials":"VG","Suffix":"Jr","AffiliationInfo":[{"Affiliation":"Division of Infectious Diseases, Department of Medicine, Duke University Durham NC USA."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Ruzin","ForeName":"Alexey","Initials":"A","AffiliationInfo":[{"Affiliation":"Microbial Sciences, AstraZeneca Gaithersburg MD USA."}]}]},"Language":["eng"],"PublicationTypeList":{"PublicationType":[{"@attributes":{"UI":"D016428"},"@text":"Journal Article"}]},"ArticleDate":[{"@attributes":{"DateType":"Electronic"},"Year":"2019","Month":"07","Day":"19"}]},"MedlineJournalInfo":{"Country":"Australia","MedlineTA":"Clin Transl Immunology","NlmUniqueID":"101638268","ISSNLinking":"2050-0068"},"KeywordList":[{"@attributes":{"Owner":"NOTNLM"},"Keyword":[{"@attributes":{"MajorTopicYN":"N"},"@text":"Staphylococcus aureus"},{"@attributes":{"MajorTopicYN":"N"},"@text":"antibody response"},{"@attributes":{"MajorTopicYN":"N"},"@text":"bacteremia"},{"@attributes":{"MajorTopicYN":"N"},"@text":"patient outcome"},{"@attributes":{"MajorTopicYN":"N"},"@text":"pneumonia"},{"@attributes":{"MajorTopicYN":"N"},"@text":"virulence"}]}]},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2019","Month":"3","Day":"6"},{"@attributes":{"PubStatus":"revised"},"Year":"2019","Month":"6","Day":"24"},{"@attributes":{"PubStatus":"accepted"},"Year":"2019","Month":"6","Day":"30"},{"@attributes":{"PubStatus":"entrez"},"Year":"2019","Month":"7","Day":"31","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2019","Month":"7","Day":"31","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2019","Month":"7","Day":"31","Hour":"6","Minute":"1"},{"@attributes":{"PubStatus":"pmc-release"},"Year":"2019","Month":"7","Day":"19"}]},"PublicationStatus":"epublish","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"31360464"},{"@attributes":{"IdType":"pmc"},"@text":"PMC6640002"},{"@attributes":{"IdType":"doi"},"@text":"10.1002\/cti2.1070"},{"@attributes":{"IdType":"pii"},"@text":"CTI21070"}]},"ReferenceList":[{"Reference":[{"Citation":"David MZ, Daum RS. Community\u2010associated methicillin\u2010resistant <i>Staphylococcus aureus<\/i>: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev\n2010; 23: 616\u2013687.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC2901661"},{"@attributes":{"IdType":"pubmed"},"@text":"20610826"}]}},{"Citation":"Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin\u2010resistant <i>Staphylococcus aureus<\/i>, United States, 1999\u20132005. Emerg Infect Dis\n2007; 13: 1840\u20131846.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC2876761"},{"@attributes":{"IdType":"pubmed"},"@text":"18258033"}]}},{"Citation":"Klevens RM, Morrison MA, Nadle J\n<i>et\u00a0al<\/i>\nInvasive methicillin\u2010resistant <i>Staphylococcus aureus<\/i> infections in the United States. JAMA\n2007; 298: 1763\u20131771.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"17940231"}]}},{"Citation":"Kuehnert MJ, Hill HA, Kupronis BA\n<i>et\u00a0al<\/i>\nMethicillin\u2010resistant <i>Staphylococcus aureus<\/i> hospitalizations, United States. Emerg Infect Dis\n2005; 11: 868\u2013872.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC3367609"},{"@attributes":{"IdType":"pubmed"},"@text":"15963281"}]}},{"Citation":"De la Calle C, Morata L, Cobos\u2010Trigueros N\n<i>et\u00a0al<\/i>\n\n<i>Staphylococcus aureus<\/i> bacteremic pneumonia. Eur J Clin Microbiol Infect Dis\n2016; 35: 497\u2013502.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"26780692"}]}},{"Citation":"Boucher HW, Talbot GH, Bradley JS\n<i>et\u00a0al<\/i>\nBad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis\n2009; 48: 1\u201312.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"19035777"}]}},{"Citation":"Fowler VG Jr, Boucher HW, Corey GR\n<i>et\u00a0al<\/i>\nDaptomycin versus standard therapy for bacteremia and endocarditis caused by <i>Staphylococcus aureus<\/i>\n. N Engl J Med\n2006; 355: 653\u2013665.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"16914701"}]}},{"Citation":"Sanchez Garcia M, de la Torre MA, Morales G\n<i>et\u00a0al<\/i>\nClinical outbreak of linezolid\u2010resistant <i>Staphylococcus aureus<\/i> in an intensive care unit. JAMA\n2010; 303: 2260\u20132264.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"20530779"}]}},{"Citation":"Thammavongsa V, Kim HK, Missiakas D\n<i>et\u00a0al<\/i>\nStaphylococcal manipulation of host immune responses. Nat Rev Microbiol\n2015; 13: 529\u2013543.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC4625792"},{"@attributes":{"IdType":"pubmed"},"@text":"26272408"}]}},{"Citation":"Jacobsson G, Colque\u2010Navarro P, Gustafsson E\n<i>et\u00a0al<\/i>\nAntibody responses in patients with invasive <i>Staphylococcus aureus<\/i> infections. Eur J Clin Microbiol Infect Dis\n2010; 29: 715\u2013725.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"20383551"}]}},{"Citation":"Adhikari RP, Ajao AO, Aman MJ\n<i>et\u00a0al<\/i>\nLower antibody levels to <i>Staphylococcus aureus<\/i> exotoxins are associated with sepsis in hospitalized adults with invasive <i>S. aureus<\/i> infections. J Infect Dis\n2012; 206: 915\u2013923.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"22807524"}]}},{"Citation":"Fritz SA, Tiemann KM, Hogan PG\n<i>et\u00a0al<\/i>\nA serologic correlate of protective immunity against community\u2010onset <i>Staphylococcus aureus<\/i> infection. Clin Infect Dis\n2013; 56: 1554\u20131561.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC3641868"},{"@attributes":{"IdType":"pubmed"},"@text":"23446627"}]}},{"Citation":"Sharma\u2010Kuinkel BK, Wu Y, Tabor DE\n<i>et\u00a0al<\/i>\nCharacterization of alpha\u2010toxin <i>hla<\/i> gene variants, alpha\u2010toxin expression levels, and levels of antibody to alpha\u2010toxin in hemodialysis and postsurgical patients with <i>Staphylococcus aureus<\/i> bacteremia. J Clin Microbiol\n2015; 53: 227\u2013236.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC4290928"},{"@attributes":{"IdType":"pubmed"},"@text":"25392350"}]}},{"Citation":"Wu Y, Liu X, Akhgar A\n<i>et\u00a0al<\/i>\nPrevalence of IgG and neutralizing antibodies against <i>Staphylococcus aureus<\/i> alpha\u2010toxin in healthy human subjects and diverse patient populations. Infect Immun\n2018; 86: e00671\u201317.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC5820940"},{"@attributes":{"IdType":"pubmed"},"@text":"29263109"}]}},{"Citation":"Bubeck Wardenburg J, Patel RJ, Schneewind O. Surface proteins and exotoxins are required for the pathogenesis of <i>Staphylococcus aureus<\/i> pneumonia. Infect Immun\n2007; 75: 1040\u20131044.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC1828520"},{"@attributes":{"IdType":"pubmed"},"@text":"17101657"}]}},{"Citation":"Foster TJ, Geoghegan JA, Ganesh VK\n<i>et\u00a0al<\/i>\nAdhesion, invasion and evasion: the many functions of the surface proteins of <i>Staphylococcus aureus<\/i>\n. Nat Rev Microbiol\n2014; 12: 49\u201362.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC5708296"},{"@attributes":{"IdType":"pubmed"},"@text":"24336184"}]}},{"Citation":"Alonzo FI, Torres VJ. The bicomponent pore\u2010forming leucocidins of <i>Staphylococcus aureus<\/i>\n. Microbiol Mol Biol Rev\n2014; 78: 199\u2013230.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC4054254"},{"@attributes":{"IdType":"pubmed"},"@text":"24847020"}]}},{"Citation":"Diep BA, Phung Q, Date S\n<i>et\u00a0al<\/i>\nIdentifying potential therapeutic targets of methicillin\u2010resistant <i>Staphylococcus aureus<\/i> through <i>in\u00a0vivo<\/i> proteomic analysis. J Infect Dis\n2014; 209: 1533\u20131541.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC3997574"},{"@attributes":{"IdType":"pubmed"},"@text":"24280367"}]}},{"Citation":"Thomsen IP, Dumont AL, James DB\n<i>et\u00a0al<\/i>\nChildren with invasive <i>Staphylococcus aureus<\/i> disease exhibit a potently neutralizing antibody response to the cytotoxin LukAB. Infect Immun\n2014; 82: 1234\u20131242.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC3957992"},{"@attributes":{"IdType":"pubmed"},"@text":"24379282"}]}},{"Citation":"Handke LD, Hawkins JC, Miller AA\n<i>et\u00a0al<\/i>\nRegulation of <i>Staphylococcus aureus<\/i> MntC expression and its role in response to oxidative stress. PLoS One\n2013; 8: e77874.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC3810276"},{"@attributes":{"IdType":"pubmed"},"@text":"24205007"}]}},{"Citation":"Jenkins A, Diep BA, Mai TT\n<i>et\u00a0al<\/i>\nDifferential expression and roles of <i>Staphylococcus aureus<\/i> virulence determinants during colonization and disease. MBio\n2015; 6: e02272\u201302214.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC4337569"},{"@attributes":{"IdType":"pubmed"},"@text":"25691592"}]}},{"Citation":"Dinges MM, Orwin PM, Schlievert PM. Exotoxins of <i>Staphylococcus aureus<\/i>\n. Clin Microbiol Rev\n2000; 13: 16\u201334.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC88931"},{"@attributes":{"IdType":"pubmed"},"@text":"10627489"}]}},{"Citation":"O'Reilly M, Kreiswirth B, Foster TJ. Cryptic alpha\u2010toxin gene in toxic shock syndrome and septicaemia strains of <i>Staphylococcus aureus<\/i>\n. Mol Microbiol\n1990; 4: 1947\u20131955.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"2082151"}]}},{"Citation":"DeLeo FR, Kennedy AD, Chen L\n<i>et\u00a0al<\/i>\nMolecular differentiation of historic phage\u2010type 80\/81 and contemporary epidemic <i>Staphylococcus aureus<\/i>\n. Proc Natl Acad Sci USA\n2011; 108: 18091\u201318096.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC3207694"},{"@attributes":{"IdType":"pubmed"},"@text":"22025717"}]}},{"Citation":"Nienaber JJ, Sharma Kuinkel BK, Clarke\u2010Pearson M\n<i>et\u00a0al<\/i>\nMethicillin\u2010susceptible <i>Staphylococcus aureus<\/i> endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins. J Infect Dis\n2011; 204: 704\u2013713.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC3156104"},{"@attributes":{"IdType":"pubmed"},"@text":"21844296"}]}},{"Citation":"Tabor DE, Yu L, Mok H\n<i>et\u00a0al<\/i>\n\n<i>Staphylococcus aureus<\/i> alpha\u2010toxin is conserved among diverse hospital respiratory isolates collected from a global surveillance study and is neutralized by monoclonal antibody MEDI4893. Antimicrob Agents Chemother\n2016; 60: 5312\u20135321.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC4997823"},{"@attributes":{"IdType":"pubmed"},"@text":"27324766"}]}},{"Citation":"Bayer AS, Ramos MD, Menzies BE\n<i>et\u00a0al<\/i>\nHyperproduction of alpha\u2010toxin by <i>Staphylococcus aureus<\/i> results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect Immun\n1997; 65: 4652\u20134660.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC175667"},{"@attributes":{"IdType":"pubmed"},"@text":"9353046"}]}},{"Citation":"Patti JM, Allen BL, McGavin MJ\n<i>et\u00a0al<\/i>\nMSCRAMM\u2010mediated adherence of microorganisms to host tissues. Annu Rev Microbiol\n1994; 48: 585\u2013617.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"7826020"}]}},{"Citation":"Foster TJ, Hook M. Surface protein adhesins of <i>Staphylococcus aureus<\/i>\n. Trends Microbiol\n1998; 6: 484\u2013488.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"10036727"}]}},{"Citation":"Schneewind O, Fowler A, Faull KF. Structure of the cell wall anchor of surface proteins in <i>Staphylococcus aureus<\/i>\n. Science\n1995; 268: 103\u2013106.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"7701329"}]}},{"Citation":"Dumont AL, Nygaard TK, Watkins RL\n<i>et\u00a0al<\/i>\nCharacterization of a new cytotoxin that contributes to <i>Staphylococcus aureus<\/i> pathogenesis. Mol Microbiol\n2011; 79: 814\u2013825.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC3312031"},{"@attributes":{"IdType":"pubmed"},"@text":"21255120"}]}},{"Citation":"DuMont AL, Yoong P, Surewaard BG\n<i>et\u00a0al<\/i>\n\n<i>Staphylococcus aureus<\/i> elaborates leukocidin AB to mediate escape from within human neutrophils. Infect Immun\n2013; 81: 1830\u20131841.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC3648020"},{"@attributes":{"IdType":"pubmed"},"@text":"23509138"}]}},{"Citation":"Janesch P, Rouha H, Weber S\n<i>et\u00a0al<\/i>\nSelective sensitization of human neutrophils to LukGH\u2010mediated cytotoxicity by <i>Staphylococcus aureus<\/i> and IL\u20108. J Infect\n2017; 74: 473\u2013483.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"28237625"}]}},{"Citation":"Inouye M, Dashnow H, Raven LA\n<i>et\u00a0al<\/i>\nSRST2: Rapid genomic surveillance for public health and hospital microbiology labs. Genome Med\n2014; 6: 90.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC4237778"},{"@attributes":{"IdType":"pubmed"},"@text":"25422674"}]}},{"Citation":"Bankevich A, Nurk S, Antipov D\n<i>et\u00a0al<\/i>\nSPAdes: a new genome assembly algorithm and its applications to single\u2010cell sequencing. J Comput Biol\n2012; 19: 455\u2013477.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC3342519"},{"@attributes":{"IdType":"pubmed"},"@text":"22506599"}]}},{"Citation":"Gardner SN, Slezak T, Hall BG. kSNP3.0: SNP detection and phylogenetic analysis of genomes without genome alignment or reference genome. Bioinformatics 2015; 31: 2877\u20132878.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"25913206"}]}},{"Citation":"Letunic I, Bork P. Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res 2016; 44: W242\u2013W245.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC4987883"},{"@attributes":{"IdType":"pubmed"},"@text":"27095192"}]}},{"Citation":"Tkaczyk C, Hua L, Varkey R\n<i>et\u00a0al<\/i>\nIdentification of anti\u2010alpha toxin monoclonal antibodies that reduce the severity of <i>Staphylococcus aureus<\/i> dermonecrosis and exhibit a correlation between affinity and potency. Clin Vaccine Immunol\n2012; 19: 377\u2013385.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC3294626"},{"@attributes":{"IdType":"pubmed"},"@text":"22237895"}]}},{"Citation":"Hua L, Hilliard JJ, Shi Y\n<i>et\u00a0al<\/i>\nAssessment of an anti\u2010alpha\u2010toxin monoclonal antibody for prevention and treatment of <i>Staphylococcus aureus<\/i>\u2010induced pneumonia. Antimicrob Agents Chemother\n2014; 58: 1108\u20131117.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pmc"},"@text":"PMC3910899"},{"@attributes":{"IdType":"pubmed"},"@text":"24295977"}]}}]}]}}}